Short communication · 18 Dec 2018
CommentaryPublished 2012
Lung Cancer Staging
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer incidence has dramatically risen in the past century. It is now the leading cause of cancer death in the world, both among men and women. Accurate staging is important because treatment options and prognosis differ significantly by stage. If there are no distant metastases, the status of mediastinal lymph nodes is the critical point to distinct between patients who will benefit from surgical therapy, neoadjuvant therapy or clinical treatment. Noninvasive imaging studies including chest computed tomography and positron emission tomography scanning should be performed in all patients who are potentially candidates to pulmonary resection. The findings of these noninvasive studies are critical, and the invasive mediastinal staging must be performed according to the medical examination and the results of noninvasive tests. In patients with extensive mediastinal infiltration by lung cancer, the disease is considered advanced and invasive staging is not needed. In patients with mediastinal lymph node enlargement seen at computed tomography, a sample tissue of these nodes is necessary. In these cases there are several methods to invasive staging the mediastinum, but mediastinoscopy is the gold standard. In patients with clinical T2 or with central tumors, invasive staging of the mediastinal nodes is necessary. Patients with a peripheral clinical T1 lung cancer do not usually need invasive confirmation of mediastinal nodes unless there is an abnormal standard uptake value in the nodes, found on positron emission tomography scanning. The staging of patients with left upper lobe tumors should include an assessment of the preaortic and aortopulmonary window lymph nodes. Pancoast tumors always need invasive mediastinal staging if they are considered for surgical resection.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 22 May 2023
Relationship between Cardiac Toxicities and Radiation Dose in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy for Tumors Adjacent to the Heart
Case report · 29 Dec 2022
Improved Survival Outcome with Flat Dosing Pembrolizumab (Pembroxim®) in Late-Stage Non-Small Cell Lung Cancer- A Case Report
Commentary · 3 Nov 2022
Stages of Non-Small Cell Lung Cancer and Antineoplastic Therapy
Research article · 15 Nov 2018
Comparison of IMRT and VMAT Plan for Advanced Stage Non-Small Cell Lung Cancer Treatment
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Filipe Moreira de Andrade”
- BylineArticles whose byline prints “Luiz Felippe Judice”
- BylineArticles whose byline prints “Paulo de Biasi”
- BylineArticles whose byline prints “Robert Cerfolio”

